Your session is about to expire
← Back to Search
Observational for Pancreatic Cancer
N/A
Waitlist Available
Led By Patrick J Worth
Research Sponsored by OHSU Knight Cancer Institute
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up assessed at surgery number 15, approximate 6 months
Awards & highlights
Study Summary
This study evaluates the use of indocyanine green to predict postoperative pancreatic leaks in patients undergoing transection of the pancreas.
Eligible Conditions
- Pancreatic Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ assessed at surgery number 15, approximate 6 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~assessed at surgery number 15, approximate 6 months
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Incidence of biochemical leak or fistula after pancreatectomy.
Perfusion status
Secondary outcome measures
Best practice usage of ICG for pancreatic surgery
Leak grade by ICG metrics
Leak grade via ISGPS classification
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients receive indocyanine green IV during surgery, undergo imaging and have their medical records reviewed on study.
Find a Location
Who is running the clinical trial?
OHSU Knight Cancer InstituteLead Sponsor
230 Previous Clinical Trials
2,090,671 Total Patients Enrolled
Patrick J WorthPrincipal InvestigatorOHSU Knight Cancer Institute
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger